Arena Pharma ticks higher on Nasdaq delisting notice for Pfizer deal - NewsBreak

Seeking Alpha

New York City, NY

ABOUT

Seeking Alpha is an industry leader in mining the wisdom of the crowds for insights on every topic of interest to investors. Our editors curate investing news and analysis from a network of stock analysts, traders, economists, academics, financial advisers and industry experts — all who engage in our community.

 https://seekingalpha.com
IN THIS ARTICLE
YOU MAY ALSO LIKE

By Joshua Fineman

Seeking Alpha

 1 day ago

Arena Pharmaceuticals (NASDAQ:ARNA) rose 1.1% in after hours trading after a Nasdaq delisting notice indicated the company's last trading day would be Thursday due to the completion of its sale to Pfizer Inc (NYSE:PFE)....

seekingalpha.com

Comments / 0

Related

Novavax expects to apply for full approval of COVID vaccine in H2

Feb 28 (Reuters) - Novavax Inc (NVAX.O) said on Monday it would pursue full approval of its COVID-19 vaccine in the second half of this year and forecast total revenue of between $4 billion and $5 billion for 2022. "We expect to gain additional authorizations where we have already filed,...

3 Dirt-Cheap Dividend Stocks to Buy in March

Wall Street thinks all three of these stocks could jump by double-digit percentages over the next 12 months.

Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash

These two companies stand to hold up through recessions because of their business models.

Novavax earns bullish views from analysts on outlook for COVID-19 vaccine

Novavax (NVAX +0.3%) is set to close higher on Tuesday for the fourth straight session as Wall Street cheers the outlook for its COVID-19 vaccine despite lower-than-expected financials posted by the Maryland-based biotech yesterday. Named NVX-CoV2373, the protein-based vaccine has been cleared by more than a dozen regulatory agencies worldwide,...

IN THIS ARTICLE

Arena Pharma gains after report Pfizer deal will clear without HSR second request

Arena Pharmaceuticals (NASDAQ:ARNA) rose 3.5% in after hours trading on a report that its planned sale to Pfizer Inc. (NYSE:PFE) won't require a longer review from the Federal Trade Commission, according a Dealreporter item. The waiting period under the Hart-Scott Rodino ("HSR") act for the deal is expected to expire...

Pfizer's CEO says Jared Kushner wanted him to divert vaccine supplies from Canada, Japan, and Latin America to boost the US's COVID-19 jab stockpile

Albert Bourla said Kushner thought the US should come first and said the government could "take measures" to enforce its will and get COVID-19 shots.

Occidental Petroleum Is Firing On All Cylinders

The company is coming back from what looked like an impossible situation. Occidental Petroleum (OXY) is coming back from what looks like one of the worst timed acquisitions in recent memory. The actual takeover itself is something I have seen many companies execute successfully. This particular acquisition was followed by an OPEC pricing war and the coronavirus demand destruction. That was certainly an unexpected and likely unprecedented string of bad luck. But investors are now benefitting from yet another unforeseen twist of future events. Here comes the good luck.

YOU MAY ALSO LIKE

Why Nvidia, Micron, and AMD Stocks Popped Tuesday

More worries over semiconductor shortages spark a relief rally today.

Apple Stock Premarket: Buy At Jim Cramer’s Entry Price?

On Tuesday, February 22, Apple stock (AAPL) - Get Apple Inc. Report sank once again. This was the fifth straight time that AAPL shares ended the trading day in the red, this time down by 1.8%. But here’s the silver lining: after declining almost 10% from a recent peak reached...

The U.S. is about to approve a fourth COVID vaccine that could be a silver bullet solution to the anti-vax crisis

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you. It might not be long until a fourth COVID vaccine is available in the U.S., and it’s a big deal. Novavax Inc.’s COVID-19 vaccine is on...

2 Dividend Kings And Princes To Buy In March

"There is only one criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend payout for a minimum of 50 consecutive years." - Dogs of the Dow. Foreword. As supplement to this article, please note that Dogs of the Dow has published a...

Maverix Metals buys three royalties on Nevada gold projects

Maverix Metals (NYSE:MMX) +5.3% pre-market after agreeing to acquire a package of three royalties on gold projects in Nevada from Waterton Precious Metals Fund II Cayman LP for $5M. Maverix says the properties have strong exploration and development potential for gold while providing immediate cash flow through advance royalty payments.

Pfizer and Moderna set to make $51 BILLION in COVID-19 vaccine sales in 2022: Global health leaders call for pharma companies to make shots available in the developing world

Pfizer and Moderna, manufacturers of the two most popular used vaccines in the United States and much of the rest of the world, are expecting to bring in $51 billion in vaccine sales this year, according to earnings statements published by the companies. Pfizer expects to lead the way, with...

My Top 2 Buffett Stocks to Buy and Hold in 2022 (and Beyond)

Emulating successful investors can help you build a strong portfolio.

Walgreens teams up with Labcorp for free at-home COVID test kits

Walgreens (NASDAQ:WBA) is partnering with Labcorp (NYSE:LH) to provide the Pixel by Labcorp (LH) COVID-19 at-home collection kit for free to individuals who meet certain clinical guidelines. To qualify, an individual must be experiencing mild symptoms; exposed to someone with COVID-19; live or work in a congregate setting; and/or asked...

Seekingalpha.com

Eco Wave Power Global plans to apply for delisting from Nasdaq First North in Stockholm

Eco Wave Power Global (WAVE) plans to apply for delisting from Nasdaq First North Growth Market in Stockholm as it shifts attention to its recent listing on the Nasdaq Capital Market. The formal application for delisting will be submitted to Nasdaq First North no earlier than 3 months from Feb....

Tuesday’s Top Analyst Upgrades and Downgrades: AMD, Baxter, Constellation Energy, CrowdStrike, Datadog, Nutrien, SentinelOne, Zhihu and More

Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Constellation Energy, CrowdStrike, Datadog, Nutrien, Sandstorm Gold, SentinelOne and Zhihu.

Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec. 31, 2021. Net loss for the fourth quarter was $155.6 million compared to a net loss of $122.2 million for the same period in 2020. Basic and diluted net loss per share for...

Why Pfizer Shares Are Trading Higher Today

Pfizer Inc (NYSE: PFE) is trading higher Wednesday after the company received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for PF-06482077, or RSVpreF, the company's respiratory syncytial virus vaccine candidate. The FDA’s Breakthrough Therapy Designation is designed to expedite the development and review of drugs intended to...

Seeking Alpha

New York City, NY

ABOUT

Seeking Alpha is an industry leader in mining the wisdom of the crowds for insights on every topic of interest to investors. Our editors curate investing news and analysis from a network of stock analysts, traders, economists, academics, financial advisers and industry experts — all who engage in our community.

 https://seekingalpha.com
https://www.newsbreak.com/news/2536358370602/arena-pharma-ticks-higher-on-nasdaq-delisting-notice-for-pfizer-deal